User menu

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.

Bibliographic reference Lizak, Nathaniel ; Lugaresi, Alessandra ; Alroughani, Raed ; Lechner-Scott, Jeannette ; Slee, Mark ; et. al. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.. In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 0, no.1-8, p. jnnp-2016-313976 (2016)
Permanent URL http://hdl.handle.net/2078.1/177590
  1. Pharmaceutical Management Agency (PHARMAC), Notification: decisions relating to multiple sclerosis treatments (2014)
  2. Trojano, Neurology, 69, 1478 (2007)
  3. Lublin, Ann Neurol, 49, 677 (2001)
  4. Frischer, Brain, 132, 1175 (2009)
  5. Goodin, Neurology, 78, 1315 (2012)
  6. Bates, Neurology, 76, S14 (2011)
  7. Vosoughi, Clin Neurol Neurosurg, 112, 365 (2010)
  8. Freedman, Neurology, 76, S26 (2011)
  9. Kalincik, PLoS ONE, 7, e50101 (2012)
  10. Lublin, Neurology, 61, 1528 (2003)
  11. Confavreux, N Engl J Med, 343, 1430 (2000)
  12. Filippini, Cochrane Database Syst Rev, CD008933 (2013)
  13. Confavreux, Lancet Neurol, 13, 247 (2014)
  14. Schumacher, Ann N Y Acad Sci, 122, 552 (1965)
  15. Kalincik, Brain, 138, 3287 (2015)
  16. Kalincik, Mult Scler
  17. Butzkueven, Mult Scler, 12, 769 (2006)
  18. Paz Soldán, Neurology, 84, 81 (2015)
  19. Giovannoni, N Engl J Med, 362, 416 (2010)
  20. Gold, N Engl J Med, 367, 1098 (2012)
  21. Coles, N Engl J Med, 359, 1786 (2008)
  22. Cohen, N Engl J Med, 362, 402 (2010)
  23. Rudick, N Engl J Med, 354, 911 (2006)
  24. Stys, Nat Rev Neurosci, 13, 507 (2012)
  25. Kurtzke, Neurology, 33, 1444 (1983)
  26. Scalfari, Brain, 133, 1914 (2010)
  27. Leray, Brain, 133, 1900 (2010)
  28. Confavreux, Brain, 126, 770 (2003)
  29. McKelvey C. DMT Discontinuation Review Stirs MS Research Community. In: Multiple Sclerosis Discovery Forum. http://www.msdiscovery.org/news/news_synthesis/15162-dmt-discontinuation-review-stirs-ms-research-community (accessed 6 Mar 2016).
  30. Butler, Decisional dilemmas in discontinuing prolonged disease-modifying treatment for multiple sclerosis (2015)